Health : Medical Research
The Multiple Myeloma Research Foundation
Funding treatments. Finding a cure.
Rating
| Overall Rating |  |
||
| (61.79) | |||
| Organizational Efficiency | |||
| Program Expenses | 92.9% | ||
| Administrative Expenses | 2.7% | ||
| Fundraising Expenses | 4.3% | ||
| Fundraising Efficiency | $0.03 | ||
| Efficiency Rating |  |
||
| (39.29) | |||
| Organizational Capacity | |||
| Primary Revenue Growth | 23.1% | ||
| Program Expenses Growth | 20.7% | ||
| Working Capital Ratio (years) | 0.19 | ||
| Capacity Rating | |
||
| (22.50) |
Income Statement (FYE 12/2007)
Contact Information
The Multiple Myeloma Research Foundation
383 Main Avenue
5th Floor
Norwalk, CT 06851
tel: (203) 229-0464
EIN: 06-1504413
Leadership (FYE 12/2007)
| Name | Title | Compensation | % of Expenses | Compensation from Affiliates |
|---|---|---|---|---|
| Kathy Giusti | Chief Executive Officer, Founder (The person identified as holding the highest position of management, and therefore who would normally be responsible for carrying out the mission of the charity and leading the organization on a day-to-day basis.) | $137,224 | 0.70% | $137,224 |
| Other Salaries of Note | ||||
| Scott Santarella | Executive Director (Using information reported on an organization's most recent Form 990, we include as compensation an individual's salary, cash bonuses, and expense accounts and other allowances. We do not include contributions to benefit plans or compensation deferred to a future date.) | $218,860 | 1.13% | -- |
Donor Privacy Policy
YES, this charity has a written donor privacy policy.
Mission
Founded in 1998, The Multiple Myeloma Research Foundation (MMRF) works to urgently and aggressively fund research that will lead to the development of new treatments for multiple myeloma. As the world's number-one funder of myeloma research, the MMRF has raised more than $102 million to fund 70 laboratories worldwide. The MMRF's approach, with a focus on speed, innovation, and results, is widely recognized across the medical and scientific communities, as well as by several prominent publications, as an optimal model to accelerate medical research and drug development across various cancers and diseases. Today, the MMRF is supporting 30 new compounds and approaches now in clinical trials and pre-clinical studies and has facilitated 14 clinical trials through its sister organization, the Multiple Myeloma Research Consortium.
Charities Performing Similar Types of Work
| Charity Name | Overall Score | Overall Rating |
|---|---|---|
| The Multiple Myeloma Research Foundation - CT | 61.79 | |
| Lymphoma Research Foundation - NY | 58.52 |  |
| Dana-Farber Cancer Institute - MA | 63.84 | |
| Damon Runyon Cancer Research Foundation - NY | 58.34 | |
| Cancer Research Institute - NY | 55.31 | |
| Charity Name | Overall Score | Overall Rating |
|---|---|---|
| The Multiple Myeloma Research Foundation - CT | 61.79 | |
| American Institute for Cancer Research - DC | 29.12 |  |
| Breast Cancer Research Foundation - NY | 64.18 | |
| Dana-Farber Cancer Institute - MA | 63.84 | |
| Walker Cancer Research Institute - MD | 39.97 | |
| National Foundation for Cancer Research - MD | 36.02 | |
